Selvita S.A. (WSE:SLV)
Poland · Delayed Price · Currency is PLN 37.00
-1.30 (-3.39%)
Oct 3, 2025, 5:04 PM CET
Selvita Market Cap
Selvita has a market cap or net worth of 679.15 million as of October 3, 2025. Its market cap has decreased by -42.37% in one year.
Market Cap
679.15M
Enterprise Value
869.17M
Revenue
373.90M
Ranking
n/a
PE Ratio
1,460.54
Stock Price
37.00
Market Cap Chart
Since October 16, 2019, Selvita's market cap has increased from 335.40M to 679.15M, an increase of 102.49%. That is a compound annual growth rate of 12.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 679.15M | -25.25% |
| Dec 30, 2024 | 908.60M | -15.38% |
| Dec 29, 2023 | 1.07B | -29.43% |
| Dec 30, 2022 | 1.52B | 1.10% |
| Dec 30, 2021 | 1.51B | 66.33% |
| Dec 30, 2020 | 904.92M | 141.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.43B |
| NEUCA | 3.04B |
| Synektik Spólka Akcyjna | 2.19B |
| Voxel | 1.78B |
| Celon Pharma | 1.23B |
| Centrum Medyczne ENEL-MED | 523.19M |
| Ryvu Therapeutics | 520.38M |
| Bioceltix | 496.39M |